You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Safety of pandemic influenza A (H1N1)vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial in Estonia, Philippines (H5N1 antigen combined with MF59 adjuvant)

Completed
  • Influenza, Human
  • H5N1 antigen combined with MF59 adjuvant
  • Tallinn, Harjumaa, Estonia
  • +6 more
Jul 21, 2022

Influenza, Pandemic Trial in Baltimore (BW-1014: 25 µg rH5 in 20% NE - pipette - IN, BW-1014: 50 µg rH5 in 20% NE - pipette -

Recruiting
  • Influenza, Pandemic
  • BW-1014: 25 µg rH5 in 20% NE - pipette - IN
  • +5 more
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, University of
Jul 8, 2022

Pandemic Influenza Trial in United States (A/H5N1, LT Adjuvant Patch)

Completed
Has Results
  • Pandemic Influenza
  • A/H5N1
  • LT Adjuvant Patch
  • Anaheim, California
  • +5 more
Dec 9, 2021

Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)

Recruiting
  • Influenza A
  • Pandemic Influenza
  • H7HLAII
  • Oslo, Norway
    Oslo University Hospital
Sep 20, 2023

Influenza Trial in South Jordan (mRNA-1018 for H5N8, mRNA-1018 for H7N9, mRNA-1018 for H5 Only)

Recruiting
  • Influenza
  • mRNA-1018 for H5N8
  • +4 more
  • South Jordan, Utah
    J. Lewis Research, Inc/Jordan River Family Medicine
Jul 25, 2023

Pandemic Influenza Disease Trial in Tampere, München (Placebo (PL), Trivalent influenza virus vaccine (TIV), Adjuvanted

Completed
Has Results
  • Pandemic Influenza Disease
  • Placebo (PL)
  • +3 more
  • Tampere, Finland
  • +1 more
Apr 22, 2021

Influenza Trial in Baltimore (H5N1 pISV)

Completed
  • Influenza
  • H5N1 pISV
  • Baltimore, Maryland
    Center for Immunization Research, Johns Hopkins Bloomberg School
Feb 15, 2022

Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

Not yet recruiting
  • Influenza, Human
  • +4 more
  • aH5N8c on Day 1
  • +4 more
  • Cullman, Alabama
  • +8 more
May 15, 2023

Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)

Not yet recruiting
  • Influenza, Human
  • FLU Q-PAN H5N8 Formulation 1
  • +3 more
  • (no location specified)
Jul 27, 2023

Influenza Trial in Iowa City (DCVC H1 HA mRNA vaccine, Quadrivalent Recombinant Seasonal Influenza Vaccine, Sodium Chloride,

Not yet recruiting
  • Influenza
  • DCVC H1 HA mRNA vaccine
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics - Department of Internal
Jul 6, 2023

Influenza Trial in Toronto, Mirabel, Pointe-Claire (H1 influenza antigen)

Completed
  • Influenza
  • H1 influenza antigen
  • Toronto, Ontario, Canada
  • +2 more
Nov 3, 2023

H1N1v Influenza Trial in Gentofte/Copenhagen, Næstved (Focetria)

Completed
  • H1N1v Influenza
  • Focetria
  • Gentofte, Denmark
  • +1 more
Nov 14, 2022

Influenza Vaccine Trial in United States (Cam2020 M2SR H3N2 influenza vaccine, Fluzone HD IIV, IN Placebo)

Completed
  • Influenza Vaccine
  • Cam2020 M2SR H3N2 influenza vaccine
  • +3 more
  • Port Orange, Florida
  • +5 more
Nov 11, 2022

Influenza, Human Trial in Morayfield (CODA-VAX H1N1, Flucelvax Quad, Saline)

Active, not recruiting
  • Influenza, Human
  • CODA-VAX H1N1
  • +2 more
  • Morayfield, Queensland, Australia
    Amy Goh, Study Coordinator
Jun 24, 2022

Influenza A H1N1 Trial in London (Infectious Titre 1, Infectious Titre 2, Infectious Titre 3)

Recruiting
  • Influenza A H1N1
  • Infectious Titre 1
  • +3 more
  • London, United Kingdom
    hVIVO Services Ltd
Oct 6, 2022

Influenza, Human, Influenza in Birds, Respiratory Tract Infections Trial in United States (aH5N6c on Day 1, aH5N6c on Day 22,

Recruiting
  • Influenza, Human
  • +7 more
  • aH5N6c on Day 1
  • +2 more
  • Huntsville, Alabama
  • +17 more
Jul 26, 2022

Influenza, Human, Infections, Respiratory Tract Infections Trial in Philippines, United States (Low dose A/H2N3c + standard dose

Not yet recruiting
  • Influenza, Human
  • +4 more
  • Low dose A/H2N3c + standard dose MF59
  • +5 more
  • Rockville, Maryland
  • +7 more
May 26, 2023

Influenza Trial in Durham (Influenza Virus Quadrivalent Inactivated Vaccine, Sodium Chloride, 0.9%, VRC-FLUNPF099-00-VP

Not yet recruiting
  • Influenza
  • Influenza Virus Quadrivalent Inactivated Vaccine
  • +2 more
  • Durham, North Carolina
    Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
Feb 23, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Avian Influenza, H1N1 Influenza, Influenza Trial in Nashville (AS03, Influenza Virus Vaccine, Monovalent A/H3N2v

Completed
Has Results
  • Avian Influenza
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center - Vanderbilt Institute for
Jan 25, 2022

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Influenza Vaccine Trial in Anaheim, DeLand, Lenexa (Sing2016 M2SR H3N2 influenza vaccine, Placebo)

Active, not recruiting
  • Influenza Vaccine
  • Sing2016 M2SR H3N2 influenza vaccine
  • Placebo
  • Anaheim, California
  • +2 more
May 13, 2022

Influenza Prevention Trial in Lenexa, Metairie, Cincinnati (INFLUENZA G1 mHA, Placebo, Al(OH)3)

Recruiting
  • Influenza Prevention
  • INFLUENZA G1 mHA
  • +2 more
  • Lenexa, Kansas
  • +2 more
Jun 5, 2023

Seasonal Influenza Trial in United States (mRNA-1011.1, mRNA-1011.2, mRNA-1012.1)

Recruiting
  • Seasonal Influenza
  • mRNA-1011.1
  • +5 more
  • Lakewood, California
  • +21 more
Apr 12, 2023

Influenza, Human Trial (Flu mRNA, Control 1, Control 2)

Not yet recruiting
  • Influenza, Human
  • Flu mRNA
  • +2 more
  • (no location specified)
Apr 21, 2023